Next, the test was validated with around 650 blood samples donated by people in São Paulo during the Brazilian Zika epidemic (2015–17). The results showed 87.8% sensitivity (avoidance of false ...
Validated with blood samples, the test showed 87.8% sensitivity and 91.4% specificity. It can assess immunity in endemic regions and aid in monitoring vaccine efficacy, especially for dengue and Zika.